mrs KIRBY MILLER

Lobbying activities related to children's pain relieving medicines and supply chain. H.R. 3008 - Drug Shortage Prevention Act of 2023

Lobbying activities related to children's pain relieving medicines and supply chain. H.R. 3008 - Drug Shortage Prevention Act of 2023

Addition of oral care products to HSA/FSA accounts - no legislation as of yet. H.R. 4794 - Dietary Supplement Access Act

H.R. 4794 - Dietary Supplement Access Act H.R. 8599 - Oral Care Products Inclusion Act

H.R.1629 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023. H.R. 5374/S. 1843 - SHOP SAFE Act Dietary Supplement Reform issues H.R. 895 - Combatting Organized Retail Crime Act of 2023

H.R.1629 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023. H.R. 5374/S. 1843 - SHOP SAFE Act Dietary Supplement Reform issues H.R. 895 - Combatting Organized Retail Crime Act of 2023

H.R. 4794 - Dietary Supplement Access Act H.R. 8599 - Oral Care Products Inclusion Act

H.R.1629 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023. H.R. 5374/S. 1843 - SHOP SAFE Act Dietary Supplement Reform issues H.R. 895 - Combatting Organized Retail Crime Act of 2023

H.R.1629 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023. H.R. 5374/S. 1843 - SHOP SAFE Act Dietary Supplement Reform issues H.R. 895 - Combatting Organized Retail Crime Act of 2023

OTC Switch - general advocacy on Prescription to Over-the-Counter Switch of medications and ingredients. Proposed rule for Nonprescription Drug Product with an Additional Condition for Nonprescription Use H.R. 2964/S. 1350 - The Wastewater Infrastructure Pollution Prevention and Environmental Safety Act or the WIPPES Act FDA Nonprescription Drugs Advisory Committee Meeting on Phenylephrine Activities related to Over-the-Counter Monograph Drug User Fee Drug Enforcement Administration Pseudoephedrine quotas

OTC Switch - general advocacy on Prescription to Over-the-Counter Switch of medications and ingredients. Proposed rule for Nonprescription Drug Product with an Additional Condition for Nonprescription Use H.R. 2964/S. 1350 - The Wastewater Infrastructure Pollution Prevention and Environmental Safety Act or the WIPPES Act FDA Nonprescription Drugs Advisory Committee Meeting on Phenylephrine Activities related to Over-the-Counter Monograph Drug User Fee Drug Enforcement Administration Pseudoephedrine quotas

S.150 - Affordable Prescriptions for Patients Act of 2023 Pandemic and All Hazards Preparedness Act Reauthorization Over-the-Counter access to oral contraception FDA Modernization Act 3.0 Dietary Supplement Listing Act Reauthorization of the Over the Counter Monograph User Fee Act (OMUFA) Wastewater Infrastructure Pollution Prevention and Environmental Safety Act or the WIPPES Act

S.150 - Affordable Prescriptions for Patients Act of 2023 Pandemic and All Hazards Preparedness Act Reauthorization Over-the-Counter access to oral contraception FDA Modernization Act 3.0 Dietary Supplement Listing Act Reauthorization of the Over the Counter Monograph User Fee Act (OMUFA)

H.R.1629 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023. H.R. 5374/S. 1843 - SHOP SAFE Act Dietary Supplement Reform issues H.R. 895 - Combatting Organized Retail Crime Act of 2023

H.R.1629 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023. H.R. 5374/S. 1843 - SHOP SAFE Act Dietary Supplement Reform issues H.R. 895 - Combatting Organized Retail Crime Act of 2023

H.R.1629 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023. H.R. 5374/S. 1843 - SHOP SAFE Act Dietary Supplement Reform issues

H.R.1629 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023. Anticounterfeiting, SHOP SAFE Act - no legislation as of yet. Dietary Supplement Reform issues

H.R.1629 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023. Anticounterfeiting, SHOP SAFE Act - no legislation as of yet. Dietary Supplement Reform issues

H.R.1629 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023. H.R. 5374/S. 1843 - SHOP SAFE Act Dietary Supplement Reform issues H.R. 895 - Combatting Organized Retail Crime Act of 2023

OTC Switch - general advocacy on Prescription to Over-the-Counter Switch of medications and ingredients. Proposed rule for Nonprescription Drug Product with an Additional Condition for Nonprescription Use H.R. 2964/S. 1350 - The Wastewater Infrastructure Pollution Prevention and Environmental Safety Act or the WIPPES Act FDA Nonprescription Drugs Advisory Committee Meeting on Phenylephrine Activities related to Over-the-Counter Monograph Drug User Fee Drug Enforcement Administration Pseudoephedrine quotas

OTC Switch - general advocacy on Prescription to Over-the-Counter Switch of medications and ingredients. Proposed rule for Nonprescription Drug Product with an Additional Condition for Nonprescription Use H.R. 2964/S. 1350 - The Wastewater Infrastructure Pollution Prevention and Environmental Safety Act or the WIPPES Act FDA Nonprescription Drugs Advisory Committee Meeting on Phenylephrine Activities related to Over-the-Counter Monograph Drug User Fee

Lobbying activities related to children's pain relieving medicines and supply chain. H.R. 3008 - Drug Shortage Prevention Act of 2023

Lobbying activities related to children's pain relieving medicines and supply chain. H.R. 3008 - Drug Shortage Prevention Act of 2023

Lobbying activities related to children's pain relieving medicines and supply chain. H.R. 3008 - Drug Shortage Prevention Act of 2023

Addition of oral care products to HSA/FSA accounts - no legislation as of yet. H.R. 4794 - Dietary Supplement Access Act

Addition of oral care products to HSA/FSA accounts - no legislation as of yet. H.R. 4794 - Dietary Supplement Access Act

H.R.1629 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023. H.R. 5374/S. 1843 - SHOP SAFE Act Dietary Supplement Reform issues

H.R.1629 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023. H.R. 5374/S. 1843 - SHOP SAFE Act Dietary Supplement Reform issues H.R. 895 - Combatting Organized Retail Crime Act of 2023

H.R.1629 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023. H.R. 5374/S. 1843 - SHOP SAFE Act Dietary Supplement Reform issues H.R. 895 - Combatting Organized Retail Crime Act of 2023

OTC Switch - general advocacy on Prescription to Over-the-Counter Switch of medications and ingredients. Proposed rule for Nonprescription Drug Product with an Additional Condition for Nonprescription Use H.R. 2964/S. 1350 - The Wastewater Infrastructure Pollution Prevention and Environmental Safety Act or the WIPPES Act FDA Nonprescription Drugs Advisory Committee Meeting on Phenylephrine Activities related to Over-the-Counter Monograph Drug User Fee

OTC Switch - general advocacy on Prescription to Over-the-Counter Switch of medications and ingredients. Proposed rule for Nonprescription Drug Product with an Additional Condition for Nonprescription Use H.R. 2964/S. 1350 - The Wastewater Infrastructure Pollution Prevention and Environmental Safety Act or the WIPPES Act FDA Nonprescription Drugs Advisory Committee Meeting on Phenylephrine Activities related to Over-the-Counter Monograph Drug User Fee Drug Enforcement Administration Pseudoephedrine quotas

S.150 - Affordable Prescriptions for Patients Act of 2023 Pandemic and All Hazards Preparedness Act Reauthorization Over-the-Counter access to oral contraception

S.150 - Affordable Prescriptions for Patients Act of 2023

S.150 - Affordable Prescriptions for Patients Act of 2023 Pandemic and All Hazards Preparedness Act Reauthorization Over-the-Counter access to oral contraception

S.150 - Affordable Prescriptions for Patients Act of 2023 Pandemic and All Hazards Preparedness Act Reauthorization Over-the-Counter access to oral contraception

H.R.1629 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023. H.R. 5374/S. 1843 - SHOP SAFE Act Dietary Supplement Reform issues

H.R.1629 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023. H.R. 5374/S. 1843 - SHOP SAFE Act Dietary Supplement Reform issues H.R. 895 - Combatting Organized Retail Crime Act of 2023

S.380 - Health Savings Act of 2021 H.R.373 - To treat certain face coverings and disinfectants as medical expenses for purposes of certain Federal tax benefits. H.R.1319 - American Rescue Plan Act of 2021 S.1654 - A bill to amend the Internal Revenue Code of 1986 to include certain over-the-counter dietary supplement products as qualified medical expenses. H.R.5214 - To amend the Internal Revenue Code of 1986 to permit expenditures from health savings accounts, flexible spending arrangements, and health reimbursement arrangements for dietary supplements. H.R.6271 - Health Savings Act of 2021 H.R.5747 - To amend the Internal Revenue Code of 1986 to include certain over-the-counter dietary supplement products as qualified medical expenses.

S.380 - Health Savings Act of 2021 H.R.373 - To treat certain face coverings and disinfectants as medical expenses for purposes of certain Federal tax benefits. H.R.1319 - American Rescue Plan Act of 2021 S.1654 - A bill to amend the Internal Revenue Code of 1986 to include certain over-the-counter dietary supplement products as qualified medical expenses. H.R.5214 - To amend the Internal Revenue Code of 1986 to permit expenditures from health savings accounts, flexible spending arrangements, and health reimbursement arrangements for dietary supplements. H.R.6271 - Health Savings Act of 2021 H.R.5747 - To amend the Internal Revenue Code of 1986 to include certain over-the-counter dietary supplement products as qualified medical expenses.

H.R.2051 - To designate methamphetamine as an emerging threat, and for other purposes S.854 - A bill to designate methamphetamine as an emerging threat, and for other purposes H.R.3617 - MORE Act of 2021 H.R.2591/S.957 - DUMP Opioids Act S.2628 - Better ODDS To Reduce Diversion Act of 2021 H.R.5086 - Safe Disposal of Opioids Act of 2021 H.R.5382/S.2853 - POWER Act H.R.4350 - National Defense Authorization Act for Fiscal Year 2022

H.R.2051 - To designate methamphetamine as an emerging threat, and for other purposes S.854 - A bill to designate methamphetamine as an emerging threat, and for other purposes H.R.3617 - MORE Act of 2021 H.R.2591/S.957 - DUMP Opioids Act S.2628 - Better ODDS To Reduce Diversion Act of 2021 H.R.5086 - Safe Disposal of Opioids Act of 2021 H.R.5382/S.2853 - POWER Act H.R.4350 - National Defense Authorization Act for Fiscal Year 2022

S.984/H.R. 2238 - A bill to amend the Solid Waste Disposal Act to reduce the production and use of certain single-use plastic products and packaging, to improve the responsibility of producers in the design, collection, reuse, recycling, and disposal of their consumer products and packaging, to prevent pollution from consumer products and packaging from entering into animal and human food chains and waterways, and for other purposes. H.R.4800 - Reef Safe Act of 2021 S.2546 - Reef Safe Act of 2021

S.984/H.R. 2238 - A bill to amend the Solid Waste Disposal Act to reduce the production and use of certain single-use plastic products and packaging, to improve the responsibility of producers in the design, collection, reuse, recycling, and disposal of their consumer products and packaging, to prevent pollution from consumer products and packaging from entering into animal and human food chains and waterways, and for other purposes. H.R.4800 - Reef Safe Act of 2021 S.2546 - Reef Safe Act of 2021

H.R.2051 - To designate methamphetamine as an emerging threat, and for other purposes S.854 - A bill to designate methamphetamine as an emerging threat, and for other purposes H.R.3617 - MORE Act of 2021 H.R.2591/S.957 - DUMP Opioids Act S.2628 - Better ODDS To Reduce Diversion Act of 2021 H.R.5086 - Safe Disposal of Opioids Act of 2021 H.R.5382/S.2853 - POWER Act H.R.4350 - National Defense Authorization Act for Fiscal Year 2022

H.R.2051 - To designate methamphetamine as an emerging threat, and for other purposes S.854 - A bill to designate methamphetamine as an emerging threat, and for other purposes H.R.3617 - MORE Act of 2021 H.R.2591/S.957 - DUMP Opioids Act S.2628 - Better ODDS To Reduce Diversion Act of 2021 H.R.5086 - Safe Disposal of Opioids Act of 2021 H.R.5382/S.2853 - POWER Act H.R.4350 - National Defense Authorization Act for Fiscal Year 2022

OTC switch process -- no bill number H.R. 6000 - 21st Century Cures 2.0 S.1435/HR 2873 - Affordable Prescriptions for Patients Act of 2021 H.R.4405 - Small Business FDA User Fee Adjustment Act of 2021 H.R. 7667 - Food and Drug Amendments of 2022 Dietary Supplement Reform -- no bill number Cosmetics Reform -- (Included in H.R. 2617, Consolidated Appropriations Act of 2023) S. 4348 - Food and Drug Administration Safety and Landmark Advancements Act of 2022 or the FDASLA Act of 2022 Genus vs. FDA Circuit Court Lobby Activity -- (Included in H.R. 2617, Consolidated Appropriations Act of 2023) S. 4535 - Food and Drug Administration Simple Reauthorization Act of 2022 or the "FDASRA Act of 2022" H.R.6833 - Making continuing appropriations for fiscal year 2023, and for other purposes H.R.2617 - Consolidated Appropriations Act, 2023 H.R.7776 - James M. Inhofe National Defense Authorization Act for Fiscal Year 2023

S.936 - A bill to require online marketplaces to collect, verify, and disclose certain information regarding high-volume third party sellers of consumer products to inform consumers. S.1843 -- SHOP SAFE Act H.R.7756 - INFORM Consumers Act H.Res.436 - Supporting State, local, and community initiatives to encourage parents, teachers, camp counselors, and childcare professionals to take measures to prevent sunburns in the minors they care for, and expressing the sense of the House of Representatives that State, local, and community entities should continue to support efforts to curb the incidences of skin cancer beginning with childhood skin protection. S.Res.144 - A resolution recognizing the week of March 21 through March 27, 2021, as "National Poison Prevention Week" and encouraging communities across the United States to raise awareness of the dangers of poisoning and promote poison prevention. H.R.5374 - SHOP SAFE Act S.1260 - United States Innovation and Competition Act of 2021 H.R.2731 - Endless Frontier Act

S.936 - A bill to require online marketplaces to collect, verify, and disclose certain information regarding high-volume third party sellers of consumer products to inform consumers. S.1843 -- SHOP SAFE Act H.R.7756 - INFORM Consumers Act H.Res.436 - Supporting State, local, and community initiatives to encourage parents, teachers, camp counselors, and childcare professionals to take measures to prevent sunburns in the minors they care for, and expressing the sense of the House of Representatives that State, local, and community entities should continue to support efforts to curb the incidences of skin cancer beginning with childhood skin protection. S.Res.144 - A resolution recognizing the week of March 21 through March 27, 2021, as "National Poison Prevention Week" and encouraging communities across the United States to raise awareness of the dangers of poisoning and promote poison prevention. H.R.5374 - SHOP SAFE Act S.1260 - United States Innovation and Competition Act of 2021 H.R.2731 - Endless Frontier Act

OTC switch process -- no bill number H.R. 6000 - 21st Century Cures 2.0 S.1435/HR 2873 - Affordable Prescriptions for Patients Act of 2021 H.R.4405 - Small Business FDA User Fee Adjustment Act of 2021 H.R. 7667 - Food and Drug Amendments of 2022 Dietary Supplement Reform -- no bill number Cosmetics Reform -- (Included in H.R. 2617, Consolidated Appropriations Act of 2023) S. 4348 - Food and Drug Administration Safety and Landmark Advancements Act of 2022 or the FDASLA Act of 2022 Genus vs. FDA Circuit Court Lobby Activity -- (Included in H.R. 2617, Consolidated Appropriations Act of 2023) S. 4535 - Food and Drug Administration Simple Reauthorization Act of 2022 or the "FDASRA Act of 2022" H.R.6833 - Making continuing appropriations for fiscal year 2023, and for other purposes H.R.2617 - Consolidated Appropriations Act, 2023 H.R.7776 - James M. Inhofe National Defense Authorization Act for Fiscal Year 2023

OTC switch process -- no bill number H.R. 6000 - 21st Century Cures 2.0 S.1435/HR 2873 - Affordable Prescriptions for Patients Act of 2021 H.R.4405 - Small Business FDA User Fee Adjustment Act of 2021 H.R. 7667 - Food and Drug Amendments of 2022 Dietary Supplement Reform -- no bill number Cosmetics Reform -- no bill number S. 4348 - Food and Drug Administration Safety and Landmark Advancements Act of 2022 or the FDASLA Act of 2022 Genus vs. FDA Circuit Court Lobby Activity S. 4535 - Food and Drug Administration Simple Reauthorization Act of 2022 or the "FDASRA Act of 2022" H.R.6833 - Making continuing appropriations for fiscal year 2023, and for other purposes

OTC switch process -- no bill number H.R. 6000 - 21st Century Cures 2.0 S.1435/HR 2873 - Affordable Prescriptions for Patients Act of 2021 H.R.4405 - Small Business FDA User Fee Adjustment Act of 2021 H.R. 7667 - Food and Drug Amendments of 2022 Dietary Supplement Reform -- no bill number Cosmetics Reform -- no bill number S. 4348 - Food and Drug Administration Safety and Landmark Advancements Act of 2022 or the FDASLA Act of 2022 Genus vs. FDA Circuit Court Lobby Activity

OTC switch process -- no bill number H.R. 6000 - 21st Century Cures 2.0 S.1435/HR 2873 - Affordable Prescriptions for Patients Act of 2021 H.R.4405 - Small Business FDA User Fee Adjustment Act of 2021 H.R. 7667 - Food and Drug Amendments of 2022 Dietary Supplement Reform -- no bill number Cosmetics Reform -- no bill number S. 4348 - Food and Drug Administration Safety and Landmark Advancements Act of 2022 or the FDASLA Act of 2022 Genus vs. FDA Circuit Court Lobby Activity

H.R.2051 - To designate methamphetamine as an emerging threat, and for other purposes S.854 - A bill to designate methamphetamine as an emerging threat, and for other purposes H.R.3617 - MORE Act of 2021 H.R.2591/S.957 - DUMP Opioids Act S.2628 - Better ODDS To Reduce Diversion Act of 2021 H.R.5086 - Safe Disposal of Opioids Act of 2021 H.R.5382/S.2853 - POWER Act H.R.4350 - National Defense Authorization Act for Fiscal Year 2022

H.R.2051 - To designate methamphetamine as an emerging threat, and for other purposes S.854 - A bill to designate methamphetamine as an emerging threat, and for other purposes H.R.3617 - MORE Act of 2021 H.R.2591/S.957 - DUMP Opioids Act S.2628 - Better ODDS To Reduce Diversion Act of 2021 H.R.5086 - Safe Disposal of Opioids Act of 2021 H.R.5382/S.2853 - POWER Act H.R.4350 - National Defense Authorization Act for Fiscal Year 2022

Proposals impacting the pharmaceutical supply chain -- no bill number S.2100 - A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety of cosmetics. H.R.3990/S. 2047 - To ban the use of intentionally added perfluoroalkyl or polyfluoroalkyl substances in cosmetics. H.R.5376 - Build Back Better Act H.R.3684 - Infrastructure Investment and Jobs Act

Proposals impacting the pharmaceutical supply chain -- no bill number S.2100 - A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety of cosmetics. H.R.3990/S. 2047 - To ban the use of intentionally added perfluoroalkyl or polyfluoroalkyl substances in cosmetics. H.R.5376 - Build Back Better Act H.R.3684 - Infrastructure Investment and Jobs Act

S.380 - Health Savings Act of 2021 H.R.373 - To treat certain face coverings and disinfectants as medical expenses for purposes of certain Federal tax benefits. H.R.1319 - American Rescue Plan Act of 2021 S.1654 - A bill to amend the Internal Revenue Code of 1986 to include certain over-the-counter dietary supplement products as qualified medical expenses. H.R.5214 - To amend the Internal Revenue Code of 1986 to permit expenditures from health savings accounts, flexible spending arrangements, and health reimbursement arrangements for dietary supplements. H.R.6271 - Health Savings Act of 2021 H.R.5747 - To amend the Internal Revenue Code of 1986 to include certain over-the-counter dietary supplement products as qualified medical expenses.

S.380 - Health Savings Act of 2021 H.R.373 - To treat certain face coverings and disinfectants as medical expenses for purposes of certain Federal tax benefits. H.R.1319 - American Rescue Plan Act of 2021 S.1654 - A bill to amend the Internal Revenue Code of 1986 to include certain over-the-counter dietary supplement products as qualified medical expenses. H.R.5214 - To amend the Internal Revenue Code of 1986 to permit expenditures from health savings accounts, flexible spending arrangements, and health reimbursement arrangements for dietary supplements. H.R.6271 - Health Savings Act of 2021 H.R.5747 - To amend the Internal Revenue Code of 1986 to include certain over-the-counter dietary supplement products as qualified medical expenses.

Proposals impacting the pharmaceutical supply chain -- no bill number S.2100 - A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety of cosmetics. H.R.3990/S. 2047 - To ban the use of intentionally added perfluoroalkyl or polyfluoroalkyl substances in cosmetics. H.R.5376 - Build Back Better Act H.R.3684 - Infrastructure Investment and Jobs Act

Proposals impacting the pharmaceutical supply chain -- no bill number S.2100 - A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety of cosmetics. H.R.3990/S. 2047 - To ban the use of intentionally added perfluoroalkyl or polyfluoroalkyl substances in cosmetics. H.R.5376 - Build Back Better Act H.R.3684 - Infrastructure Investment and Jobs Act

H.R.2051 - To designate methamphetamine as an emerging threat, and for other purposes S.854 - A bill to designate methamphetamine as an emerging threat, and for other purposes H.R.3617 - MORE Act of 2021 H.R.2591/S.957 - DUMP Opioids Act S.2628 - Better ODDS To Reduce Diversion Act of 2021 H.R.5086 - Safe Disposal of Opioids Act of 2021 H.R.5382/S.2853 - POWER Act H.R.4350 - National Defense Authorization Act for Fiscal Year 2022

H.R.2051 - To designate methamphetamine as an emerging threat, and for other purposes S.854 - A bill to designate methamphetamine as an emerging threat, and for other purposes H.R.3617 - MORE Act of 2021 H.R.2591/S.957 - DUMP Opioids Act S.2628 - Better ODDS To Reduce Diversion Act of 2021 H.R.5086 - Safe Disposal of Opioids Act of 2021 H.R.5382/S.2853 - POWER Act H.R.4350 - National Defense Authorization Act for Fiscal Year 2022

OTC switch process -- no bill number H.R. 6000 - 21st Century Cures 2.0 S.1435/HR 2873 - Affordable Prescriptions for Patients Act of 2021 H.R.4405 - Small Business FDA User Fee Adjustment Act of 2021 H.R. 7667 - Food and Drug Amendments of 2022 Dietary Supplement Reform -- no bill number Cosmetics Reform -- no bill number S. 4348 - Food and Drug Administration Safety and Landmark Advancements Act of 2022 or the FDASLA Act of 2022 Genus vs. FDA Circuit Court Lobby Activity

OTC switch process -- no bill number H.R. 6000 - 21st Century Cures 2.0 S.1435/HR 2873 - Affordable Prescriptions for Patients Act of 2021 H.R.4405 - Small Business FDA User Fee Adjustment Act of 2021 H.R. 7667 - Food and Drug Amendments of 2022 Dietary Supplement Reform -- no bill number Cosmetics Reform -- (Included in H.R. 2617, Consolidated Appropriations Act of 2023) S. 4348 - Food and Drug Administration Safety and Landmark Advancements Act of 2022 or the FDASLA Act of 2022 Genus vs. FDA Circuit Court Lobby Activity -- (Included in H.R. 2617, Consolidated Appropriations Act of 2023) S. 4535 - Food and Drug Administration Simple Reauthorization Act of 2022 or the "FDASRA Act of 2022" H.R.6833 - Making continuing appropriations for fiscal year 2023, and for other purposes H.R.2617 - Consolidated Appropriations Act, 2023 H.R.7776 - James M. Inhofe National Defense Authorization Act for Fiscal Year 2023

OTC switch process -- no bill number H.R. 6000 - 21st Century Cures 2.0 S.1435/HR 2873 - Affordable Prescriptions for Patients Act of 2021 H.R.4405 - Small Business FDA User Fee Adjustment Act of 2021 H.R. 7667 - Food and Drug Amendments of 2022 Dietary Supplement Reform -- no bill number Cosmetics Reform -- no bill number S. 4348 - Food and Drug Administration Safety and Landmark Advancements Act of 2022 or the FDASLA Act of 2022 Genus vs. FDA Circuit Court Lobby Activity S. 4535 - Food and Drug Administration Simple Reauthorization Act of 2022 or the "FDASRA Act of 2022" H.R.6833 - Making continuing appropriations for fiscal year 2023, and for other purposes

OTC switch process -- no bill number H.R. 6000 - 21st Century Cures 2.0 S.1435/HR 2873 - Affordable Prescriptions for Patients Act of 2021 H.R.4405 - Small Business FDA User Fee Adjustment Act of 2021 H.R. 7667 - Food and Drug Amendments of 2022 Dietary Supplement Reform -- no bill number Cosmetics Reform -- no bill number S. 4348 - Food and Drug Administration Safety and Landmark Advancements Act of 2022 or the FDASLA Act of 2022 Genus vs. FDA Circuit Court Lobby Activity

S.984/H.R. 2238 - A bill to amend the Solid Waste Disposal Act to reduce the production and use of certain single-use plastic products and packaging, to improve the responsibility of producers in the design, collection, reuse, recycling, and disposal of their consumer products and packaging, to prevent pollution from consumer products and packaging from entering into animal and human food chains and waterways, and for other purposes. H.R.4800 - Reef Safe Act of 2021 S.2546 - Reef Safe Act of 2021

S.984/H.R. 2238 - A bill to amend the Solid Waste Disposal Act to reduce the production and use of certain single-use plastic products and packaging, to improve the responsibility of producers in the design, collection, reuse, recycling, and disposal of their consumer products and packaging, to prevent pollution from consumer products and packaging from entering into animal and human food chains and waterways, and for other purposes. H.R.4800 - Reef Safe Act of 2021 S.2546 - Reef Safe Act of 2021

H.R.2051 - To designate methamphetamine as an emerging threat, and for other purposes S.854 - A bill to designate methamphetamine as an emerging threat, and for other purposes H.R.3617 - MORE Act of 2021 H.R.2591/S.957 - DUMP Opioids Act S.2628 - Better ODDS To Reduce Diversion Act of 2021 H.R.5086 - Safe Disposal of Opioids Act of 2021 H.R.5382/S.2853 - POWER Act H.R.4350 - National Defense Authorization Act for Fiscal Year 2022

H.R.2051 - To designate methamphetamine as an emerging threat, and for other purposes S.854 - A bill to designate methamphetamine as an emerging threat, and for other purposes H.R.3617 - MORE Act of 2021 H.R.2591/S.957 - DUMP Opioids Act S.2628 - Better ODDS To Reduce Diversion Act of 2021 H.R.5086 - Safe Disposal of Opioids Act of 2021 H.R.5382/S.2853 - POWER Act H.R.4350 - National Defense Authorization Act for Fiscal Year 2022

S.380 - Health Savings Act of 2021 H.R.373 - To treat certain face coverings and disinfectants as medical expenses for purposes of certain Federal tax benefits. H.R.1319 - American Rescue Plan Act of 2021 S.1654 - A bill to amend the Internal Revenue Code of 1986 to include certain over-the-counter dietary supplement products as qualified medical expenses. H.R.5214 - To amend the Internal Revenue Code of 1986 to permit expenditures from health savings accounts, flexible spending arrangements, and health reimbursement arrangements for dietary supplements. H.R.6271 - Health Savings Act of 2021 H.R.5747 - To amend the Internal Revenue Code of 1986 to include certain over-the-counter dietary supplement products as qualified medical expenses.

S.380 - Health Savings Act of 2021 H.R.373 - To treat certain face coverings and disinfectants as medical expenses for purposes of certain Federal tax benefits. H.R.1319 - American Rescue Plan Act of 2021 S.1654 - A bill to amend the Internal Revenue Code of 1986 to include certain over-the-counter dietary supplement products as qualified medical expenses. H.R.5214 - To amend the Internal Revenue Code of 1986 to permit expenditures from health savings accounts, flexible spending arrangements, and health reimbursement arrangements for dietary supplements. H.R.6271 - Health Savings Act of 2021 H.R.5747 - To amend the Internal Revenue Code of 1986 to include certain over-the-counter dietary supplement products as qualified medical expenses.

S.936 - A bill to require online marketplaces to collect, verify, and disclose certain information regarding high-volume third party sellers of consumer products to inform consumers. S.1843 -- SHOP SAFE Act H.R.7756 - INFORM Consumers Act H.Res.436 - Supporting State, local, and community initiatives to encourage parents, teachers, camp counselors, and childcare professionals to take measures to prevent sunburns in the minors they care for, and expressing the sense of the House of Representatives that State, local, and community entities should continue to support efforts to curb the incidences of skin cancer beginning with childhood skin protection. S.Res.144 - A resolution recognizing the week of March 21 through March 27, 2021, as "National Poison Prevention Week" and encouraging communities across the United States to raise awareness of the dangers of poisoning and promote poison prevention. H.R.5374 - SHOP SAFE Act S.1260 - United States Innovation and Competition Act of 2021 H.R.2731 - Endless Frontier Act

S.936 - A bill to require online marketplaces to collect, verify, and disclose certain information regarding high-volume third party sellers of consumer products to inform consumers. S.1843 -- SHOP SAFE Act H.R.7756 - INFORM Consumers Act H.Res.436 - Supporting State, local, and community initiatives to encourage parents, teachers, camp counselors, and childcare professionals to take measures to prevent sunburns in the minors they care for, and expressing the sense of the House of Representatives that State, local, and community entities should continue to support efforts to curb the incidences of skin cancer beginning with childhood skin protection. S.Res.144 - A resolution recognizing the week of March 21 through March 27, 2021, as "National Poison Prevention Week" and encouraging communities across the United States to raise awareness of the dangers of poisoning and promote poison prevention. H.R.5374 - SHOP SAFE Act S.1260 - United States Innovation and Competition Act of 2021 H.R.2731 - Endless Frontier Act

Proposals impacting the pharmaceutical supply chain -- no bill number S.2100 - A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety of cosmetics. H.R.3990/S. 2047 - To ban the use of intentionally added perfluoroalkyl or polyfluoroalkyl substances in cosmetics. H.R.5376 - Build Back Better Act H.R.3684 - Infrastructure Investment and Jobs Act

Proposals impacting the pharmaceutical supply chain -- no bill number S.2100 - A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety of cosmetics. H.R.3990/S. 2047 - To ban the use of intentionally added perfluoroalkyl or polyfluoroalkyl substances in cosmetics. H.R.5376 - Build Back Better Act H.R.3684 - Infrastructure Investment and Jobs Act

H.R.2051 - To designate methamphetamine as an emerging threat, and for other purposes S.854 - A bill to designate methamphetamine as an emerging threat, and for other purposes H.R.3617 - MORE Act of 2021 H.R.2591/S.957 - DUMP Opioids Act S.2628 - Better ODDS To Reduce Diversion Act of 2021 H.R.5086 - Safe Disposal of Opioids Act of 2021 H.R.5382/S.2853 - POWER Act H.R.4350 - National Defense Authorization Act for Fiscal Year 2022

H.R.2051 - To designate methamphetamine as an emerging threat, and for other purposes S.854 - A bill to designate methamphetamine as an emerging threat, and for other purposes H.R.3617 - MORE Act of 2021 H.R.2591/S.957 - DUMP Opioids Act S.2628 - Better ODDS To Reduce Diversion Act of 2021 H.R.5086 - Safe Disposal of Opioids Act of 2021 H.R.5382/S.2853 - POWER Act H.R.4350 - National Defense Authorization Act for Fiscal Year 2022

S.380 - Health Savings Act of 2021 H.R.373 - To treat certain face coverings and disinfectants as medical expenses for purposes of certain Federal tax benefits. H.R.1319 - American Rescue Plan Act of 2021 S.1654 - A bill to amend the Internal Revenue Code of 1986 to include certain over-the-counter dietary supplement products as qualified medical expenses. H.R.5214 - To amend the Internal Revenue Code of 1986 to permit expenditures from health savings accounts, flexible spending arrangements, and health reimbursement arrangements for dietary supplements. H.R.6271 - Health Savings Act of 2021 H.R.5747 - To amend the Internal Revenue Code of 1986 to include certain over-the-counter dietary supplement products as qualified medical expenses.

S.380 - Health Savings Act of 2021 H.R.373 - To treat certain face coverings and disinfectants as medical expenses for purposes of certain Federal tax benefits. H.R.1319 - American Rescue Plan Act of 2021 S.1654 - A bill to amend the Internal Revenue Code of 1986 to include certain over-the-counter dietary supplement products as qualified medical expenses. H.R.5214 - To amend the Internal Revenue Code of 1986 to permit expenditures from health savings accounts, flexible spending arrangements, and health reimbursement arrangements for dietary supplements. H.R.6271 - Health Savings Act of 2021 H.R.5747 - To amend the Internal Revenue Code of 1986 to include certain over-the-counter dietary supplement products as qualified medical expenses.

OTC switch process -- no bill number H.R. 6000 - 21st Century Cures 2.0 S.1435/HR 2873 - Affordable Prescriptions for Patients Act of 2021 H.R.4405 - Small Business FDA User Fee Adjustment Act of 2021 H.R. 7667 - Food and Drug Amendments of 2022 Dietary Supplement Reform -- no bill number Cosmetics Reform -- (Included in H.R. 2617, Consolidated Appropriations Act of 2023) S. 4348 - Food and Drug Administration Safety and Landmark Advancements Act of 2022 or the FDASLA Act of 2022 Genus vs. FDA Circuit Court Lobby Activity -- (Included in H.R. 2617, Consolidated Appropriations Act of 2023) S. 4535 - Food and Drug Administration Simple Reauthorization Act of 2022 or the "FDASRA Act of 2022" H.R.6833 - Making continuing appropriations for fiscal year 2023, and for other purposes H.R.2617 - Consolidated Appropriations Act, 2023 H.R.7776 - James M. Inhofe National Defense Authorization Act for Fiscal Year 2023

OTC switch process -- no bill number H.R. 6000 - 21st Century Cures 2.0 S.1435/HR 2873 - Affordable Prescriptions for Patients Act of 2021 H.R.4405 - Small Business FDA User Fee Adjustment Act of 2021 H.R. 7667 - Food and Drug Amendments of 2022 Dietary Supplement Reform -- no bill number Cosmetics Reform -- no bill number S. 4348 - Food and Drug Administration Safety and Landmark Advancements Act of 2022 or the FDASLA Act of 2022 Genus vs. FDA Circuit Court Lobby Activity S. 4535 - Food and Drug Administration Simple Reauthorization Act of 2022 or the "FDASRA Act of 2022" H.R.6833 - Making continuing appropriations for fiscal year 2023, and for other purposes

OTC switch process -- no bill number H.R. 6000 - 21st Century Cures 2.0 S.1435/HR 2873 - Affordable Prescriptions for Patients Act of 2021 H.R.4405 - Small Business FDA User Fee Adjustment Act of 2021 H.R. 7667 - Food and Drug Amendments of 2022 Dietary Supplement Reform -- no bill number Cosmetics Reform -- no bill number S. 4348 - Food and Drug Administration Safety and Landmark Advancements Act of 2022 or the FDASLA Act of 2022 Genus vs. FDA Circuit Court Lobby Activity

OTC switch process -- no bill number H.R. 6000 - 21st Century Cures 2.0 S.1435/HR 2873 - Affordable Prescriptions for Patients Act of 2021 H.R.4405 - Small Business FDA User Fee Adjustment Act of 2021 H.R. 7667 - Food and Drug Amendments of 2022 Dietary Supplement Reform -- no bill number Cosmetics Reform -- no bill number S. 4348 - Food and Drug Administration Safety and Landmark Advancements Act of 2022 or the FDASLA Act of 2022 Genus vs. FDA Circuit Court Lobby Activity

S.380 - Health Savings Act of 2021 H.R.373 - To treat certain face coverings and disinfectants as medical expenses for purposes of certain Federal tax benefits. H.R.1319 - American Rescue Plan Act of 2021 S.1654 - A bill to amend the Internal Revenue Code of 1986 to include certain over-the-counter dietary supplement products as qualified medical expenses. H.R.5214 - To amend the Internal Revenue Code of 1986 to permit expenditures from health savings accounts, flexible spending arrangements, and health reimbursement arrangements for dietary supplements. H.R.6271 - Health Savings Act of 2021 H.R.5747 - To amend the Internal Revenue Code of 1986 to include certain over-the-counter dietary supplement products as qualified medical expenses.

S.380 - Health Savings Act of 2021 H.R.373 - To treat certain face coverings and disinfectants as medical expenses for purposes of certain Federal tax benefits. H.R.1319 - American Rescue Plan Act of 2021 S.1654 - A bill to amend the Internal Revenue Code of 1986 to include certain over-the-counter dietary supplement products as qualified medical expenses. H.R.5214 - To amend the Internal Revenue Code of 1986 to permit expenditures from health savings accounts, flexible spending arrangements, and health reimbursement arrangements for dietary supplements. H.R.6271 - Health Savings Act of 2021 H.R.5747 - To amend the Internal Revenue Code of 1986 to include certain over-the-counter dietary supplement products as qualified medical expenses.

OTC switch process -- no bill number H.R. 6000 - 21st Century Cures 2.0 S.1435/HR 2873 - Affordable Prescriptions for Patients Act of 2021 H.R.4405 - Small Business FDA User Fee Adjustment Act of 2021 H.R. 7667 - Food and Drug Amendments of 2022 Dietary Supplement Reform -- no bill number Cosmetics Reform -- no bill number S. 4348 - Food and Drug Administration Safety and Landmark Advancements Act of 2022 or the FDASLA Act of 2022 Genus vs. FDA Circuit Court Lobby Activity S. 4535 - Food and Drug Administration Simple Reauthorization Act of 2022 or the "FDASRA Act of 2022" H.R.6833 - Making continuing appropriations for fiscal year 2023, and for other purposes

OTC switch process -- no bill number H.R. 6000 - 21st Century Cures 2.0 S.1435/HR 2873 - Affordable Prescriptions for Patients Act of 2021 H.R.4405 - Small Business FDA User Fee Adjustment Act of 2021 H.R. 7667 - Food and Drug Amendments of 2022 Dietary Supplement Reform -- no bill number Cosmetics Reform -- (Included in H.R. 2617, Consolidated Appropriations Act of 2023) S. 4348 - Food and Drug Administration Safety and Landmark Advancements Act of 2022 or the FDASLA Act of 2022 Genus vs. FDA Circuit Court Lobby Activity -- (Included in H.R. 2617, Consolidated Appropriations Act of 2023) S. 4535 - Food and Drug Administration Simple Reauthorization Act of 2022 or the "FDASRA Act of 2022" H.R.6833 - Making continuing appropriations for fiscal year 2023, and for other purposes H.R.2617 - Consolidated Appropriations Act, 2023 H.R.7776 - James M. Inhofe National Defense Authorization Act for Fiscal Year 2023

OTC switch process -- no bill number H.R. 6000 - 21st Century Cures 2.0 S.1435/HR 2873 - Affordable Prescriptions for Patients Act of 2021 H.R.4405 - Small Business FDA User Fee Adjustment Act of 2021 H.R. 7667 - Food and Drug Amendments of 2022 Dietary Supplement Reform -- no bill number Cosmetics Reform -- no bill number S. 4348 - Food and Drug Administration Safety and Landmark Advancements Act of 2022 or the FDASLA Act of 2022 Genus vs. FDA Circuit Court Lobby Activity

OTC switch process -- no bill number H.R. 6000 - 21st Century Cures 2.0 S.1435/HR 2873 - Affordable Prescriptions for Patients Act of 2021 H.R.4405 - Small Business FDA User Fee Adjustment Act of 2021 H.R. 7667 - Food and Drug Amendments of 2022 Dietary Supplement Reform -- no bill number Cosmetics Reform -- (Included in H.R. 2617, Consolidated Appropriations Act of 2023) S. 4348 - Food and Drug Administration Safety and Landmark Advancements Act of 2022 or the FDASLA Act of 2022 Genus vs. FDA Circuit Court Lobby Activity -- (Included in H.R. 2617, Consolidated Appropriations Act of 2023) S. 4535 - Food and Drug Administration Simple Reauthorization Act of 2022 or the "FDASRA Act of 2022" H.R.6833 - Making continuing appropriations for fiscal year 2023, and for other purposes H.R.2617 - Consolidated Appropriations Act, 2023 H.R.7776 - James M. Inhofe National Defense Authorization Act for Fiscal Year 2023

OTC switch process -- no bill number H.R. 6000 - 21st Century Cures 2.0 S.1435/HR 2873 - Affordable Prescriptions for Patients Act of 2021 H.R.4405 - Small Business FDA User Fee Adjustment Act of 2021 H.R. 7667 - Food and Drug Amendments of 2022 Dietary Supplement Reform -- no bill number Cosmetics Reform -- no bill number S. 4348 - Food and Drug Administration Safety and Landmark Advancements Act of 2022 or the FDASLA Act of 2022 Genus vs. FDA Circuit Court Lobby Activity S. 4535 - Food and Drug Administration Simple Reauthorization Act of 2022 or the "FDASRA Act of 2022" H.R.6833 - Making continuing appropriations for fiscal year 2023, and for other purposes

OTC switch process -- no bill number H.R. 6000 - 21st Century Cures 2.0 S.1435/HR 2873 - Affordable Prescriptions for Patients Act of 2021 H.R.4405 - Small Business FDA User Fee Adjustment Act of 2021 H.R. 7667 - Food and Drug Amendments of 2022 Dietary Supplement Reform -- no bill number Cosmetics Reform -- no bill number S. 4348 - Food and Drug Administration Safety and Landmark Advancements Act of 2022 or the FDASLA Act of 2022 Genus vs. FDA Circuit Court Lobby Activity

S.936 - A bill to require online marketplaces to collect, verify, and disclose certain information regarding high-volume third party sellers of consumer products to inform consumers. S.1843 -- SHOP SAFE Act H.R.7756 - INFORM Consumers Act H.Res.436 - Supporting State, local, and community initiatives to encourage parents, teachers, camp counselors, and childcare professionals to take measures to prevent sunburns in the minors they care for, and expressing the sense of the House of Representatives that State, local, and community entities should continue to support efforts to curb the incidences of skin cancer beginning with childhood skin protection. S.Res.144 - A resolution recognizing the week of March 21 through March 27, 2021, as "National Poison Prevention Week" and encouraging communities across the United States to raise awareness of the dangers of poisoning and promote poison prevention. H.R.5374 - SHOP SAFE Act S.1260 - United States Innovation and Competition Act of 2021 H.R.2731 - Endless Frontier Act

S.936 - A bill to require online marketplaces to collect, verify, and disclose certain information regarding high-volume third party sellers of consumer products to inform consumers. S.1843 -- SHOP SAFE Act H.R.7756 - INFORM Consumers Act H.Res.436 - Supporting State, local, and community initiatives to encourage parents, teachers, camp counselors, and childcare professionals to take measures to prevent sunburns in the minors they care for, and expressing the sense of the House of Representatives that State, local, and community entities should continue to support efforts to curb the incidences of skin cancer beginning with childhood skin protection. S.Res.144 - A resolution recognizing the week of March 21 through March 27, 2021, as "National Poison Prevention Week" and encouraging communities across the United States to raise awareness of the dangers of poisoning and promote poison prevention. H.R.5374 - SHOP SAFE Act S.1260 - United States Innovation and Competition Act of 2021 H.R.2731 - Endless Frontier Act

OTC switch process -- no bill number H.R. 6000 - 21st Century Cures 2.0 S.1435/HR 2873 - Affordable Prescriptions for Patients Act of 2021 H.R.4405 - Small Business FDA User Fee Adjustment Act of 2021 H.R. 7667 - Food and Drug Amendments of 2022 Dietary Supplement Reform -- no bill number Cosmetics Reform -- (Included in H.R. 2617, Consolidated Appropriations Act of 2023) S. 4348 - Food and Drug Administration Safety and Landmark Advancements Act of 2022 or the FDASLA Act of 2022 Genus vs. FDA Circuit Court Lobby Activity -- (Included in H.R. 2617, Consolidated Appropriations Act of 2023) S. 4535 - Food and Drug Administration Simple Reauthorization Act of 2022 or the "FDASRA Act of 2022" H.R.6833 - Making continuing appropriations for fiscal year 2023, and for other purposes H.R.2617 - Consolidated Appropriations Act, 2023 H.R.7776 - James M. Inhofe National Defense Authorization Act for Fiscal Year 2023

H.R.841 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 S.1698 - Hemp Access and Consumer Safety Act S. 4090 - Dietary Supplement Listing Act of 2022